Perspectives on the Barrier to Resistance for Dolutegravir plus Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection
- Resource Type
- Journal
- Source
AIDS RESEARCH AND HUMAN RETROVIRUSES ; JAN 1 2020, 36 1, p13-p18, 6p.- Subject
- Language
- English
- ISSN
- 19318405